Mitsubishi UFJ Trust & Banking Corp lifted its holdings in Amrize Ltd (NYSE:AMRZ - Free Report) by 1,929.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 190,362 shares of the company's stock after buying an additional 180,984 shares during the period. Mitsubishi UFJ Trust & Banking Corp's holdings in Amrize were worth $10,295,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of the business. M&T Bank Corp purchased a new position in shares of Amrize in the fourth quarter worth about $540,000. D.A. Davidson & CO. lifted its stake in shares of Amrize by 2.8% in the fourth quarter. D.A. Davidson & CO. now owns 33,079 shares of the company's stock worth $1,789,000 after buying an additional 913 shares in the last quarter. Camelot Portfolios LLC purchased a new position in shares of Amrize in the fourth quarter worth about $843,000. Courier Capital LLC purchased a new position in shares of Amrize in the fourth quarter worth about $266,000. Finally, Vanguard Group Inc. lifted its stake in shares of Amrize by 5.6% in the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company's stock worth $1,722,500,000 after buying an additional 1,676,843 shares in the last quarter.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on AMRZ. Royal Bank Of Canada decreased their price target on shares of Amrize from $61.00 to $60.00 and set a "sector perform" rating on the stock in a research note on Friday. Wall Street Zen raised shares of Amrize from a "sell" rating to a "hold" rating in a research note on Sunday, March 1st. Oppenheimer set a $68.00 price target on shares of Amrize in a research note on Friday. Wells Fargo & Company decreased their price target on shares of Amrize from $66.00 to $65.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 15th. Finally, UBS Group raised their price target on shares of Amrize from $53.00 to $57.00 and gave the stock a "neutral" rating in a research note on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Amrize presently has an average rating of "Moderate Buy" and a consensus price target of $64.29.
View Our Latest Stock Report on AMRZ
Amrize Price Performance
Shares of AMRZ opened at $53.34 on Friday. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94. The stock has a market cap of $29.50 billion and a PE ratio of 25.52. The firm has a 50-day simple moving average of $57.86 and a two-hundred day simple moving average of $54.87. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10.
Amrize (NYSE:AMRZ - Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.02). Amrize had a return on equity of 9.88% and a net margin of 9.70%.The firm had revenue of $2.18 billion during the quarter. The firm's quarterly revenue was up 4.7% on a year-over-year basis. As a group, analysts forecast that Amrize Ltd will post 2.76 EPS for the current year.
Amrize Cuts Dividend
The company also recently declared a dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.11 dividend. The ex-dividend date is Tuesday, May 12th.
Insider Buying and Selling
In other news, insider Mario Gross purchased 3,200 shares of the firm's stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $55.29 per share, for a total transaction of $176,928.00. Following the completion of the purchase, the insider directly owned 30,947 shares of the company's stock, valued at $1,711,059.63. The trade was a 11.53% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Jan Philipp Jenisch purchased 60,000 shares of the firm's stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average price of $58.05 per share, with a total value of $3,483,000.00. Following the purchase, the chief executive officer directly owned 1,703,582 shares of the company's stock, valued at $98,892,935.10. The trade was a 3.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 77,834 shares of company stock valued at $4,511,344 over the last ninety days. 0.54% of the stock is currently owned by corporate insiders.
More Amrize News
Here are the key news stories impacting Amrize this week:
- Positive Sentiment: Vertical Research upgraded AMRZ from "hold" to "buy" and set a $70 price target (≈31% upside vs. current price), which may support upside momentum. The Fly / TickerReport
- Positive Sentiment: Company reaffirmed shareholder-friendly actions: announced a quarterly dividend (record May 12) and outlined plans to begin a previously-approved share repurchase program after Q1 results — items that can underpin the stock. (Company release / earnings commentary)
- Positive Sentiment: Significant insider and institutional buying highlighted by recent disclosures (multiple insider purchases and large institutional additions), which investors often view as a bullish signal. Quiver Quant
- Neutral Sentiment: Truist lowered its price target from $75 to $65 but maintained a "buy" rating — reduces upside vs. prior target but still constructive. Benzinga
- Neutral Sentiment: RBC trimmed its target slightly from $61 to $60 and moved to "sector perform", a modestly less bullish stance that may temper short-term upside. Benzinga
- Neutral Sentiment: Analyst consensus remains mixed but centered around a median target near $66; recent reports show a range of targets from the mid-$50s to $75, so analyst views are varied and could drive volatility as investors pick which estimates to follow.
- Negative Sentiment: Q1 results: revenue grew but EPS missed estimates and the Building Envelope (roofing) segment showed weaker demand, margin pressures and a temporary plant disruption — factors that explain recent selling pressure. Seeking Alpha - Q1 presentation
- Negative Sentiment: Market reaction and analysis pointed to seasonal Q1 cash burn and concerns about roofing demand that drove a prior intra-day slide; near-term sentiment may remain sensitive to guidance, margin recovery and cash-flow cadence. Quiver Quant
Amrize Profile
(
Free Report)
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.